Dennis M. Mulroy
Net Worth
Last updated:
What is Dennis M. Mulroy net worth?
The estimated net worth of Mr. Dennis M. Mulroy is at least $1,746,354 as of 16 Sep 2024. He owns shares worth $93,884 as insider, has earned $754,850 from insider trading and has received compensation worth at least $897,620 in AnaptysBio, Inc..
What is the salary of Dennis M. Mulroy?
Mr. Dennis M. Mulroy salary is $448,810 per year as Chief Financial Officer in AnaptysBio, Inc..
How old is Dennis M. Mulroy?
Mr. Dennis M. Mulroy is 70 years old, born in 1955.
What stocks does Dennis M. Mulroy currently own?
As insider, Mr. Dennis M. Mulroy owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
AnaptysBio, Inc. (ANAB) | Chief Financial Officer | 4,744 | $19.79 | $93,884 |
What does AnaptysBio, Inc. do?
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Dennis M. Mulroy insider trading
AnaptysBio, Inc.
Mr. Dennis M. Mulroy has made 6 insider trades between 2023-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 12,220 units of ANAB stock on 16 Sep 2024. As of 16 Sep 2024 he still owns at least 4,744 units of ANAB stock.
AnaptysBio key executives
AnaptysBio, Inc. executives and other stock owners filed with the SEC:
- Dr. Paul F. Lizzul (50) Chief Medical Officer
- Mr. Dennis M. Mulroy (70) Chief Financial Officer
- Mr. Hamza Suria (49) Pres, Chief Executive Officer & Director